Company

Island Laboratories Inc.(ILI) is a private, Canadian controlled subsidiary company of the Callahan Group of Companies (CGC) which has been operating for over 40 years in western Newfoundland and Labrador, Canada with diversified operations in oil & gas, real estate, retail, bussing, contracting, mining and manufacturing. Island Laboratories is a research and development company established in the year 2004 merging the technology and research of Helco Laboratories Ltd., of Bangladesh with the objective to commercialize naturally healthy, herbal treatments for various dermatological conditions. Stemcelex is a patented (Patent No. WO 2006/233396 A1) topical scientifically proven herbal treatment for alopecia is considered a Natural Health Product (NHP) by Health Canada Natural Health Product Directorate, has received an Exemption Number and is approved for commercialization from Island Laboratories, Inc. Stemcelex DT-Gel is another technology covered in the claims of the herein referenced patent that provides a line of dandruff treatment shampoos. The Company plans to register Stemcelex DT-Gel with Health Canada, the U.S. FDA and other regulatory authorities in countries under review, i.e. Germany, Bulgaria, Kuwait, India, Japan and Bangladesh.

Exact mechanisms of hair growth and efficacy of Stemcelex for hair growth both are supported by the Universities such as a) Molecular Genetics and Endocrine Mechanisms of Hair Growth Laura C. Alonso, Robert L. Rosenfield. The Rockefeller University, New York, N.Y. and The University of Chicago Children's Hospital, Chicago, Ill., USA), b) Male Pattern Balding may be due to Stem Cell inactivation in the Journal of Clinical Investigation a led by George Cotsarelis MD, at the University of Pennsylvania School of Medicine, And c) Communication Between Hair follicles and Melanocyte Stem Cells Key to Mystery,  study was led by Mayumi Ito, PhD, assistant professor in the Ronald O. Pereleman Department of Dermatology at New York University  Langone

                                                                                                                                                

We are confident about the scientific method of action of the product and we were able to gain FDA approval on the basis of empirical evidence from traditional use of the herbal extracts and published scientific discovery supporting the claims of method of action. The PCT patent is filed in 133 countries which will enable commercialization action as a non-prescription product within these countries.

Advocate for policies that will bring the best innovative medicines to Canadian in a timely and appropriate manner; improve Canada's global competitiveness; and make Canada a world leader in attracting pharmaceutical and biotechnology investments which are key components of the knowledge-based economy. The crucial importance of natural ingredients over synthetic chemical and pharmaceutical compounds is their enormous chemical diversity and potential for new therapeutic discoveries. It has been estimated that less than 10% of plant and 1% marine life has been tested for biological and therapeutic activity. A comparison of the makeup of compounds in established database shows that at least 40% of active compounds are absent in synthetic chemistry. An enormous opportunity exists therefore a company such as Island Laboratories Inc., with state -of-the art technology and research facilities to identify and bring to market natural products that are targeted at specific health conditions.

To conduct and promote health research in Canada.

To strive for full access to innovative medicines for all Canadians.

To communicate the role of Canada's research-based pharmaceutical companies, natural health products companies in the advancement of an effective, integrated and accessible health care system .

To work cooperatively with our partners in Canada's health care system, use of scientific protocols and process control, measured by analytical methods using high-tech equipment, ensures a consistent level of bioactivity in any prepared herbal extracts or dietary supplements.

To promote a competitive intellectual property protection and regulatory framework that encourages the discovery and development of new medicines as well as Natural Health Products in Canada.